How should I manage a patient who ran out of escitalopram (an SSRI) for two weeks, wants to become pregnant, and still requires an SSRI?

Restart Escitalopram Immediately and Continue Through Pregnancy

You should restart escitalopram now and continue it throughout pregnancy and while trying to conceive. The patient has already been off medication for 2 weeks, which puts her at significant risk for relapse, and untreated depression poses greater risks to both mother and baby than SSRI exposure 1.

Immediate Management

Restart Escitalopram Without Delay

• Resume at her previous effective dose - there is no need to taper up or switch medications 2
• The 2-week gap is concerning for potential relapse, which itself increases risks during pregnancy 3
• Escitalopram is an appropriate SSRI choice for pregnancy planning and pregnancy 4, 5

Key Counseling Points

Reassure her about SSRI safety in pregnancy:

• Current evidence shows that prenatal antidepressant exposure does NOT substantially increase risk of autism or ADHD - these associations are primarily due to the underlying maternal illness, not the medication 1
• The absolute risks of any adverse outcomes are small 6, 7
• Untreated depression carries significant risks: increased gestational diabetes, pregnancy depression, postpartum depression, decreased breastfeeding, and decreased breast milk production 3

Address specific pregnancy concerns:

• Paroxetine should be avoided due to cardiac malformation concerns, but escitalopram does not carry this same risk 4, 8
• Late pregnancy SSRI exposure may cause transient neonatal adaptation syndrome (irritability, jitteriness, feeding difficulties) that typically resolves within 1-2 weeks 5
• The risk of persistent pulmonary hypertension of the newborn (PPHN) remains unclear with conflicting evidence, but the number needed to harm is 286-351 4

Clinical Decision-Making Framework

The American Psychiatric Association and ACOG recommend continuing antidepressants during pregnancy for women who:

• Have previously relapsed when discontinuing treatment 1
• Have moderate-to-severe depression 1
• Have history of severe depression or suicide attempts 1
• Have tried psychotherapy without adequate response 1

Your patient fits these criteria - she has already demonstrated need for ongoing SSRI treatment and has now been without medication for 2 weeks.

Common Pitfalls to Avoid

1. Do NOT discontinue or taper the SSRI for pregnancy - this dramatically increases relapse risk (up to 68% relapse rate when discontinued) 9, 3
2. Do NOT switch to a different SSRI unnecessarily - escitalopram is appropriate for pregnancy, and switching introduces unnecessary risk of treatment failure 4
3. Do NOT suggest "trying without medication first" - she already requires SSRI treatment, and untreated depression worsens pregnancy outcomes 3

Monitoring Plan

• Screen for depression symptoms using validated tools (PHQ-9, Edinburgh Postnatal Depression Scale) 1
• Monitor for worsening depression or suicidal ideation, especially in the first few months 2
• Arrange early prenatal care once pregnant
• Consider fetal echocardiography if desired for reassurance, though risk is very low with escitalopram 7
• Plan for neonatal monitoring in the first week after delivery for transient adaptation symptoms 5

Breastfeeding Guidance

Escitalopram is compatible with breastfeeding 5, 2. Advise her to monitor the infant for excess sedation, restlessness, poor feeding, or poor weight gain, though these are uncommon 2.

The evidence strongly supports that the risks of untreated depression far outweigh the theoretical risks of SSRI exposure during pregnancy 6, 9, 8. Women who discontinue needed antidepressants face serious consequences including suicide attempts, as clinical experience demonstrates 9.